From: SCGB3A1 gene DNA methylation status is associated with breast cancer in Egyptian female patients
 | Tumor group (n = 50) | Normal group (n = 50) | P | ||
---|---|---|---|---|---|
Mean ± SD | Median (IQR) | Mean ± SD | Median (IQR) | ||
ATM (%) | |||||
 CpG_1 | 2.9 ± 1.8 | 2 (3) | 3.4 ± 2.2 | 3 (3) | 0.194 |
 CpG_2 | 8.3 ± 4 | 7.5 (7) | 9.6 ± 4.3 | 10 (6) | 0.356 |
 CpG_3 | 11.4 ± 5.2 | 10 (9) | 12 ± 4.8 | 12.5 (8) | 0.550 |
 CpG_4 | 4.6 ± 2.2 | 5 (3) | 5.1 ± 2.5 | 4.5 (4) | 0.495 |
 Average CpG sites | 6.8 ± 2.8 | 6.3 (4.8) | 7.5 ± 3 | 8.4 (5.3) | 0.315 |
SCGB3A1 (%) | |||||
 CpG_1 | 32.3 ± 20.7 | 22.5 (37) | 23.9 ± 17.1 | 22.5 (22) | 0.001* |
 CpG_2 | 78.6 ± 23.5 | 89.5 (47) | 69.9 ± 24.6 | 72.5 (39) | 0.010* |
 CpG_3 | 55.1 ± 24.8 | 49.5 (49) | 48 ± 22.8 | 45 (33) | 0.012* |
 CpG_4 | 29.1 ± 14.9 | 24 (29) | 20 ± 15.3 | 20 (23) | < 0.001* |
 Average CpG sites | 48.8 ± 16.6 | 49.3 (26.5) | 40.4 ± 16.3 | 43.4 (27.8) | 0.001* |